Athersys Gets Rights to Minnesota Stem Cells | GenomeWeb

NEW YORK, Dec. 11-Athersys has obtained exclusive rights to University of Minnesota stem cell technology in order to study stem cell differentiation and develop new therapeutics, the company said this morning.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.